Anne Ørbo

No ORCID on file · 2 papers in corpus · active 2016

Study types

  • article 1
  • erratum 1
erratum 2016
Erratum: HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
·doi:10.1038/bjc.2016.330

Correction to: British Journal of Cancer (2016) 115, 725–730. doi:10.1038/bjc.2016.247 Upon publication of the above paper in the British Journal of Cancer, the authors identified an error in the spelling of one of their names. The authors …

article 2016
HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
·doi:10.1038/bjc.2016.247

BACKGROUND: The aim of the present study was to investigate whether changes in the tissue expression of human epididymis-specific protein 4 (HE4) could predict therapy resistance and relapse after progestin hormone therapy for medium- and l…